Alpha-Synuclein and Lipids: The Elephant in the Room?

被引:39
作者
Sarchione, Alessia [1 ]
Marchand, Antoine [1 ]
Taymans, Jean-Marc [1 ]
Chartier-Harlin, Marie-Christine [1 ]
机构
[1] Univ Lille, INSERM, CHU Lille, UMR S 1172,Li1NCog,Lille Neurosci & Cognit, F-59000 Lille, France
关键词
alpha-synuclein; exocytosis; genetics; lipids; membranes; Parkinson disease; SNARE complex; synapse; vesicle fusion; therapeutic target; GENOME-WIDE ASSOCIATION; STRIATAL DOPAMINE RELEASE; STEAROYL-COA DESATURASE; PARKINSONS-DISEASE; MICE LACKING; CSP-ALPHA; MITOCHONDRIAL DYSFUNCTION; MEMBRANE INTERACTIONS; SYNAPTIC FUNCTION; CHROMAFFIN CELLS;
D O I
10.3390/cells10092452
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Since the initial identification of alpha-synuclein (alpha-syn) at the synapse, numerous studies demonstrated that alpha-syn is a key player in the etiology of Parkinson's disease (PD) and other synucleinopathies. Recent advances underline interactions between alpha-syn and lipids that also participate in alpha-syn misfolding and aggregation. In addition, increasing evidence demonstrates that alpha-syn plays a major role in different steps of synaptic exocytosis. Thus, we reviewed literature showing (1) the interplay among alpha-syn, lipids, and lipid membranes; (2) advances of alpha-syn synaptic functions in exocytosis. These data underscore a fundamental role of alpha-syn/lipid interplay that also contributes to synaptic defects in PD. The importance of lipids in PD is further highlighted by data showing the impact of alpha-syn on lipid metabolism, modulation of alpha-syn levels by lipids, as well as the identification of genetic determinants involved in lipid homeostasis associated with alpha-syn pathologies. While questions still remain, these recent developments open the way to new therapeutic strategies for PD and related disorders including some based on modulating synaptic functions.
引用
收藏
页数:37
相关论文
共 225 条
[1]   Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansion [J].
Abbineni, Prabhodh S. ;
Bohannon, Kevin P. ;
Bittner, Mary A. ;
Axelrod, Daniel ;
Holz, Ronald W. .
NEUROSCIENCE LETTERS, 2019, 699 :134-139
[2]   Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease [J].
Abbott, Sarah K. ;
Li, Hongyun ;
Munoz, Sonia Sanz ;
Knoch, Bianca ;
Batterham, Marijka ;
Murphy, Karen E. ;
Halliday, Glenda M. ;
Garner, Brett .
MOVEMENT DISORDERS, 2014, 29 (04) :518-526
[3]   DIBMA nanodiscs keep α-synuclein folded [J].
Adao, Regina ;
Cruz, Pedro F. ;
Vaz, Daniela C. ;
Fonseca, Fatima ;
Pedersen, Jannik Nedergaard ;
Ferreira-da-Silva, Frederico ;
Brito, Rui M. M. ;
Ramos, Carlos H., I ;
Otzen, Daniel ;
Keller, Sandro ;
Bastos, Margarida .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2020, 1862 (09)
[4]   Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys [J].
Alarcon-Aris, Diana ;
Pavia-Collado, Ruben ;
Miquel-Rio, Lluis ;
Coppola-Segovia, Valentin ;
Ferres-Coy, Albert ;
Ruiz-Bronchal, Esther ;
Galofre, Mireia ;
Paz, Veronica ;
Campa, Leticia ;
Revilla, Raquel ;
Montefeltro, Andres ;
Kordower, Jeffrey H. ;
Vila, Miquel ;
Artigas, Francesc ;
Bortolozzi, Analia .
EBIOMEDICINE, 2020, 59
[5]   SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease [J].
Alcalay, Roy N. ;
Mallett, Victoria ;
Vanderperre, Benot ;
Tavassoly, Omid ;
Dauvillier, Yves ;
Wu, Richard Y. J. ;
Ruskey, Jennifer A. ;
Leblond, Claire S. ;
Ambalavanan, Amirthagowri ;
Laurent, Sandra B. ;
Spiegelman, Dan ;
Dionne-Laporte, Alexandre ;
Liong, Christopher ;
Levy, Oren A. ;
Fahn, Stanley ;
Waters, Cheryl ;
Kuo, Sheng-Han ;
Chung, Wendy K. ;
Ford, Blair ;
Marder, Karen S. ;
Kang, Un Jung ;
Hassin-Baer, Sharon ;
Greenbaum, Lior ;
Trempe, Jean-Francois ;
Wolf, Pavlina ;
Oliva, Petra ;
Zhang, Xiaokui Kate ;
Clark, Lorraine N. ;
Langlois, Melanie ;
Dion, Patrick A. ;
Fon, Edward A. ;
Dupre, Nicolas ;
Rouleau, Guy A. ;
Gan-Or, Ziv .
MOVEMENT DISORDERS, 2019, 34 (04) :526-535
[6]   Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications [J].
Alza, Natalia P. ;
Iglesias Gonzalez, Pablo A. ;
Conde, Melisa A. ;
Uranga, Romina M. ;
Salvador, Gabriela A. .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
[7]   Functional Alterations to the Nigrostriatal System in Mice Lacking All Three Members of the Synuclein Family [J].
Anwar, Sabina ;
Peters, Owen ;
Millership, Steven ;
Ninkina, Natalia ;
Doig, Natalie ;
Connor-Robson, Natalie ;
Threlfell, Sarah ;
Kooner, Gurdeep ;
Deacon, Robert M. ;
Bannerman, David M. ;
Bolam, J. Paul ;
Chandra, Sreeganga S. ;
Cragg, Stephanie J. ;
Wade-Martins, Richard ;
Buchman, Vladimir L. .
JOURNAL OF NEUROSCIENCE, 2011, 31 (20) :7264-7274
[8]   Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease [J].
Appel-Cresswell, Silke ;
Vilarino-Guell, Carles ;
Encarnacion, Mary ;
Sherman, Holly ;
Yu, Irene ;
Shah, Brinda ;
Weir, David ;
Thompson, Christina ;
Szu-Tu, Chelsea ;
Trinh, Joanne ;
Aasly, Jan O. ;
Rajput, Alex ;
Rajput, Ali H. ;
Stoessl, A. Jon ;
Farrer, Matthew J. .
MOVEMENT DISORDERS, 2013, 28 (06) :811-813
[9]   GIANT MULTILEVEL CATION CHANNELS FORMED BY ALZHEIMER-DISEASE AMYLOID BETA-PROTEIN [A-BETA-P-(1-40)] IN BILAYER-MEMBRANES [J].
ARISPE, N ;
POLLARD, HB ;
ROJAS, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10573-10577
[10]   Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides [J].
Arispe, N ;
Doh, M .
FASEB JOURNAL, 2002, 16 (12) :1526-1536